Mackenzie Financial »

Poseida Therapeutics I shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $45k 14k 3.36
2023-09-30 $36k 16k 2.25
2023-06-30 $33k 19k 1.73

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Bank Of Montreal Cadcom (BMO)
Canadian Natl Ry (CNI)
Canadian Pacific Kansas City (CP)
Apple (AAPL)
Canadian Natural Resources (CNQ)
Telus Ord (TU)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Stantec (STN)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Accenture Plc Ireland Shs Class A (ACN)

View all positions for Mackenzie Financial

Top funds holding Poseida Therapeutics I

Pentwater Capital Management
Vanguard Group
Aisling Capital Management
William Blair $ Company
Millennium Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Point72 Asset Management
MCF Advisors
Bank of America Corporation
Bank of New York Mellon
Barclays

View all funds holding Poseida Therapeutics I